Oppenheimer Asset Management Inc. increased its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 58.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,015,174 shares of the real estate investment trust's stock after purchasing an additional 375,747 shares during the period. Oppenheimer Asset Management Inc. owned 0.15% of Healthpeak Properties worth $20,527,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Cambridge Investment Research Advisors Inc. increased its holdings in shares of Healthpeak Properties by 6.9% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock worth $7,229,000 after acquiring an additional 23,135 shares during the period. Wolff Wiese Magana LLC grew its position in Healthpeak Properties by 2.9% in the 1st quarter. Wolff Wiese Magana LLC now owns 152,906 shares of the real estate investment trust's stock worth $3,092,000 after purchasing an additional 4,270 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Healthpeak Properties in the first quarter valued at approximately $411,000. Praxis Investment Management Inc. increased its stake in shares of Healthpeak Properties by 9.7% in the first quarter. Praxis Investment Management Inc. now owns 17,120 shares of the real estate investment trust's stock valued at $346,000 after purchasing an additional 1,510 shares during the period. Finally, Blue Trust Inc. raised its holdings in shares of Healthpeak Properties by 49.7% during the first quarter. Blue Trust Inc. now owns 12,355 shares of the real estate investment trust's stock valued at $250,000 after buying an additional 4,100 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.
Healthpeak Properties Price Performance
Healthpeak Properties stock traded up $0.18 during midday trading on Thursday, hitting $17.49. The company's stock had a trading volume of 7,597,521 shares, compared to its average volume of 5,241,972. Healthpeak Properties, Inc. has a 12 month low of $16.64 and a 12 month high of $23.26. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.01. The company has a market capitalization of $12.15 billion, a PE ratio of 43.74, a price-to-earnings-growth ratio of 1.97 and a beta of 1.04. The stock's 50-day moving average price is $17.50 and its 200-day moving average price is $19.16.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The company had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. During the same quarter in the previous year, the company posted $0.45 EPS. The business's revenue was up 15.9% compared to the same quarter last year. Analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The business also recently declared a dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were issued a $0.1017 dividend. The ex-dividend date was Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's dividend payout ratio is currently 305.00%.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on DOC shares. Scotiabank decreased their price objective on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a report on Monday, May 12th. Argus reiterated a "buy" rating and set a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Saturday, June 21st. Wedbush cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Finally, Wells Fargo & Company decreased their target price on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $23.27.
View Our Latest Research Report on Healthpeak Properties
Insider Activity
In related news, CEO Scott M. Brinker purchased 2,750 shares of the company's stock in a transaction that occurred on Friday, May 9th. The shares were purchased at an average price of $17.39 per share, with a total value of $47,822.50. Following the purchase, the chief executive officer now owns 204,613 shares of the company's stock, valued at $3,558,220.07. This trade represents a 1.36% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Tommy G. Thompson acquired 5,777 shares of Healthpeak Properties stock in a transaction on Wednesday, May 28th. The shares were purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the completion of the purchase, the director now directly owns 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This represents a 4.17% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 29,764 shares of company stock worth $521,909. Insiders own 0.23% of the company's stock.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.